1 hr ago
The Motley Fool
Will Obamacare Crush Medtronic's Earnings?
The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise.
Sat May 18, 2013
Avon CEO to Address Stonehill College Graduates
Sheri S. McCoy, the chief executive officer and a director of Avon Products, will deliver the keynote address at Stonehill College's 62nd Commencement on Sunday, May 19.
Fri May 17, 2013
Johnson & Johnson Outlines Poppy Supply Plans
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson and Johnson could be sourcing commercial quantities of poppies outside Tasmania in 2015.
Five lessons in corporate brand building from the big boys
Research by media monitoring company Precise, published in March 2013 says that consumers are more likely to view FMCG companies favourably if they develop a recognisable corporate brand.
The Washington Post
Johnson & Johnson Ending Sales of Metal-on-Metal Hip Implants
Johnson & Johnson, the world's biggest maker of health-care products, said it will stop selling metal-on-metal and ceramic-on-metal hip replacements as demand wanes for the devices and U.S. regulators seek new rules.
Thu May 16, 2013
Retirement investors: Dividend or valued stocks?
With interest rates near zero, investors have been desperately seeking yield. As a result, one of the hottest trades for investors over the last three to four years has been buying large companies that pay high dividends.
Johnson & Johnson: At The Crossroads - Part III
In Part I of "Johnson & Johnson: At The Crossroads", consideration was given to whether a dividend growth rate of 8.2% was sustainable if net income growth rate remained around the projected 6%. It was determined that this gap between dividend and net income growth rates was likely sustainable for at least the next 15 years.
Wed May 15, 2013
This app helps you avoid supporting Monsanto and other terrible companies
When shopping in any store that carries national brands, it's virtually impossible to remember which ones you're not supposed to buy for which reasons.
The Washington Post
J&J Wins Expanded Approval of Simponi to Treat Bowel Disease
Johnson & Johnson won U.S. approval to use its rheumatoid arthritis drug Simponi to treat patients suffering from a moderate to severe inflammatory bowel disease.
Stryker's Stock Looks Pricey
Assessing whether a stock is a "value play" or a "value trap" has become a popular hobby for financial writers.
Tue May 14, 2013
What Did She Do? Congress Probes Departure of FDA Official
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! In one of the more curious departures of a high-ranking FDA official, Leona Brenner-Gati unexpectedly resigned from the agency earlier this month and did so immediately for unexplained personal reasons.
Johnson & Johnson Unit Gets Priority Revenue for Simeprevir NDA
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson & Johnson unit Janssen Research and Development LLC said the U.S. Food and Drug Administration has granted priority review to its new drug application for simeprevir, its investigational treatment of genotype 1 chronic hepatitis C in adult patients ... (more)
Buffett Style Valuation Of Johnson & Johnson
In this article, I'm going to show how much Johnson & Johnson stock is worth according to a Warren Buffett "owner earnings" style analysis.
Mon May 13, 2013
Johnson & Johnson (JNJ): What You Should Know
I'm not quite as fanatical as Warren, but I do enjoy digging into a company's annual report to learn something new.
House panel questions resignation of top FDA official
A view shows the U.S. Food and Drug Administration logo at the lobby of its headquarters in Silver Spring, Maryland August 14, 2012.
Johnson & Johnson: An Investment In A Healthcare Conglomerate That Cannot Go Wrong
It is putting in $30 million in a Band-Aid type ad campaign. This is the first time in a decade and its first global one ever that the company is indulging in a corporate re-brand ad campaign following recall of " millions of bottles and packages of Tylenol, Benadryl, Motrin and other over-the-counter medicines.
Governor Rick Scott Works to Build Up Florida Manufacturing
Today, Governor Rick Scott kicked off the Building Up Florida Manufacturing Victory Tour celebrating the elimination of the sales tax on manufacturing equipment, at Johnson and Johnson in Jacksonville.
The Jersey Journal
Janssen's experimental drug for hepatitis C gets FDA fast track
Federal regulators have granted priority review for Janssen Research & Development's experimental treatment for hepatitis C, a contagious liver disease that affects more than 3 million people in the United States.
Is Johnson & Johnson Heading Off The Patent Cliff?
Patent expiration is one of the number one reasons for pharma companies' revenue deterioration.
Johnson & Johnson: Why I'm Cautious
If there was ever a stock that defined the buy and hold investment strategy it is Johnson & Johnson .